日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EGFR and EGFRvIII coopt host defense pathways promoting progression in glioblastoma.

EGFR 和 EGFRvIII 利用宿主防御通路促进胶质母细胞瘤的进展

An Zhenyi, Fan Qi-Wen, Wang Linyu, Yoda Hiroyuki, Barata Megumi J, Jimenez-Morales David, Phillips Joanna J, Swaney Danielle L, Stevenson Erica, Lee Ethan, Krogan Nevan, Weiss William A

ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma

ATR抑制剂与靶向MYCN的烷基化PI聚酰胺协同作用,通过抑制MYCN扩增神经母细胞瘤中的DNA修复发挥作用。

Lai, Xiaoyi; Yoda, Hiroyuki; Qiao, Yuming; Kida, Yuki; Takenaga, Keizo; Shinozaki, Yoshinao; Koshikawa, Nobuko; Takatori, Atsushi

CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma

CD55是MYCN扩增型神经母细胞瘤的潜在免疫治疗靶点

Yoda, Hiroyuki; Weiss, William A

Estimating genome-wide off-target effects for pyrrole-imidazole polyamide binding by a pathway-based expression profiling approach

利用基于通路表达谱分析的方法评估吡咯-咪唑聚酰胺结合的全基因组脱靶效应

Lin, Jason; Krishnamurthy, Sakthisri; Yoda, Hiroyuki; Shinozaki, Yoshinao; Watanabe, Takayoshi; Koshikawa, Nobuko; Takatori, Atsushi; Horton, Paul; Nagase, Hiroki

Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63

致癌基因RUNX2的缺失通过诱导促凋亡蛋白TAp63增强了p53突变型胰腺癌Panc-1细胞对吉西他滨(GEM)的敏感性。

Ozaki, Toshinori; Nakamura, Mizuyo; Ogata, Takehiro; Sang, Meijie; Yoda, Hiroyuki; Hiraoka, Kiriko; Sang, Meixiang; Shimozato, Osamu